Oncology Collaboration and Licensing Agreements Report and Directory 2024: In-Depth Analysis of Stage of Development and Payment Structure of Deals
22 avr. 2024 06h56 HE
|
Research and Markets
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "Oncology Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering.Oncology Collaboration and Licensing...
United States Non-small Cell Lung Cancer Digital Marketing Analysis Report 2023: Merck's Keytruda.com Achieved the Highest Total Traffic, Followed by BMS's Opdivo.com and AstraZeneca's Imfinzi.com
19 avr. 2024 08h27 HE
|
Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "United States Digital Marketing Trends in Non-small Cell Lung Cancer" report has been added to ResearchAndMarkets.com's offering. This report...
New Field Data Shows High Diagnostic Yield for Lung Biopsy Diagnosis Using the Galaxy System™
18 avr. 2024 08h00 HE
|
Noah Medical
New Field Data Shows High Diagnostic Yield for Lung Biopsy Diagnosis Using the Galaxy System™
Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study
08 avr. 2024 16h05 HE
|
Cardiff Oncology, Inc.
RAS-mutated mCRC – In RAS-mutated mCRC, novel preclinical finding demonstrates onvansertib inhibits the tumor’s ability to adapt to hypoxia resulting in a significant decrease in both tumor...
Non-Small Cell Lung Cancer (NSCLC) Epidemiology Forecast to 2032 Across Eight Major Markets (US, France, Germany, Italy, Spain, UK, Japan and Urban China)
03 avr. 2024 11h29 HE
|
Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Non-Small Cell Lung Cancer (NSCLC): Epidemiology Forecast to 2032" report has been added to ResearchAndMarkets.com's offering.Non-small cell lung...
Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
01 avr. 2024 07h00 HE
|
Genelux Corporation
Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
28 mars 2024 17h16 HE
|
Burning Rock Biotech Limited
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
Global Generic Oncology Sterile Injectable Market Set for Rapid Growth, Forecast 2024: New Research Report
22 mars 2024 10h38 HE
|
Research and Markets
Dublin, March 22, 2024 (GLOBE NEWSWIRE) -- The "Generic Oncology Sterile Injectable Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global generic...
Global Cancer Cachexia Market Worth $2.85 Billion by 2029: Combination Therapies Gaining Traction
20 mars 2024 11h13 HE
|
Research and Markets
Dublin, March 20, 2024 (GLOBE NEWSWIRE) -- The "Cancer Cachexia Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering. This research report sheds light...
United States Cancer Contrast Media Research Analysis Report 2024-2030: Increasing Number of Clinical Studies, Rising Cancer Cases, Collaborations and Partnerships, Technological Advancements
14 mars 2024 12h05 HE
|
Research and Markets
Dublin, March 14, 2024 (GLOBE NEWSWIRE) -- The "U.S. Cancer Contrast Media Market Size, Share & Trends Analysis Report by Type (Gadolinium-based Contrast Media, Iodinated Contrast Media),...